- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Trans-resveratrol
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Trans-resveratrol
| EU orphan designation number: | EU/3/16/1827
|
| Active ingredient: | Trans-resveratrol |
| Indication: | Treatment of spinocerebellar ataxia |
| Sponsor: | Luis Pereira de Almeida
CNC- Center for Neuroscience and Cell Biology, Ed. Fac. Medicina, Rua Larga, University of Coimbra, Portugal |
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 16/01/2017 | Orphan designation | EMA/OD/209/16 | (2017)232 of 12/01/2017 |
CONTACT
EU links
Directorate General Health & Consumers